Overview

Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients

Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The goal of this project is to determine if task-activated fMRI is sensitive to the central cholinergic deficit associated with Mild Cognitive Impairment.
Phase:
N/A
Details
Lead Sponsor:
The Cleveland Clinic
Treatments:
Rivastigmine